Ebola Hemorrhagic Fever (Ebola Virus Disease)
Charles Patrick Davis, MD, PhD
Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
Jerry R. Balentine, DO, FACEP
Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.
- Ebola hemorrhagic fever (Ebola virus disease) facts
- What is Ebola hemorrhagic fever?
- What is the history of Ebola hemorrhagic fever?
- Is the Ebola virus contagious?
- What causes Ebola hemorrhagic fever?
- What are risk factors for Ebola hemorrhagic fever?
- What are Ebola virus disease symptoms and signs?
- What types of health care professionals treat Ebola hemorrhagic fever?
- What is the contagious period for the Ebola virus?
- What is the incubation period for the Ebola virus?
- How do health care professionals diagnose Ebola hemorrhagic fever?
- What is the medical treatment for Ebola hemorrhagic fever?
- What are complications of Ebola hemorrhagic fever?
- What is the prognosis of Ebola hemorrhagic fever?
- Is it possible to prevent Ebola hemorrhagic fever? Is there a vaccine for Ebola hemorrhagic fever?
- What is the latest research on Ebola hemorrhagic fever?
- Ebola Virus Slideshow Pictures
- Take the MRSA Quiz!
- Bacterial Infections 101 Slideshow Pictures
- Find a local Doctor in your town
Ebola hemorrhagic fever (Ebola virus disease) facts
- Ebola hemorrhagic fever is a disease caused by four different strains of Ebola virus; these viruses infect humans and nonhuman primates. It is also referred to as Ebola virus disease.
- Compared to most illnesses, Ebola hemorrhagic fever has a relatively short history since it was only discovered in 1976. There have been a several Ebola outbreaks, including the April 2014-May 2015 "unprecedented epidemic" in Africa, which are now abating.
- After an incubation period of two to 21 days, symptoms and signs of Ebola virus disease include
- Progression of Ebola symptoms includes
- Ebola viruses are mainly found in primates in Africa and possibly the Philippines; there are only occasional Ebola outbreaks of infection in humans. Ebola hemorrhagic fever occurs mainly in Africa in the Republic of the Congo, Gabon, Sudan, Ivory Coast, and Uganda, but it may occur in other African countries.
- Ebola virus can be spread by direct contact with blood and secretions, by contact with blood and secretions that remain on clothing, and by needles and/or syringes used to treat Ebola-infected patients.
- Risk factors for Ebola hemorrhagic fever are travel to areas with endemic Ebola hemorrhagic fever and/or any close association with infected people.
- Early clinical diagnosis is difficult as the symptoms are nonspecific; however, if the patient is suspected to have Ebola, the patient needs to be isolated and local and state health departments need to be immediately contacted.
- Definitive diagnostic tests for Ebola hemorrhagic fever are ELISA and/or PCR tests; viral cultivation and biopsy samples may also be used.
- There is no standard treatment for Ebola hemorrhagic fever; only supportive therapy and experimental treatment is available.
- There are many complications from Ebola hemorrhagic fever causing a high mortality rate (reported mortality rates equal about 25%-100%).
- Prevention of Ebola hemorrhagic fever is difficult; early testing and isolation of the patient plus barrier protection for caregivers (mask, gown, goggles, and gloves) is very important to prevent other people from getting infected.
- Researchers are trying to understand the Ebola virus and pinpoint its ecological reservoirs to better understand how Ebola outbreaks occur. Researchers are actively trying to establish an effective vaccine against Ebola viruses by using several experimental methods, but there is no vaccine available currently.
What is Ebola hemorrhagic fever?
Ebola hemorrhagic fever is a viral disease caused by Ebola virus that results in nonspecific symptoms (see symptom section of this article) early in the disease and often causes internal and external hemorrhage (bleeding) as the disease progresses. Ebola hemorrhagic fever is considered one of the most lethal viral infections; the mortality rate (death rate) is very high during outbreaks (reports of outbreaks range from about 50%-100% of people infected, depending on the Ebola strain); consequently the survival rate may range from about 50% to zero. Due to the fact that most outbreaks occur in areas where high-level intensive-care supportive services are not available, survival rates are difficult to translate to potential outbreaks in areas with more resources.
Find out what women really need.